Moderna CEO: COVID-19 accelerated manufacturing network by 5 years

Moderna CEO discusses COVID-19 risks, vaccine boosters, MRNA technology and moreПодробнее

Coronavirus: Moderna CEO on timeline for phase one vaccine resultsПодробнее

Moderna CEO discusses breakthrough in coronavirus vaccineПодробнее

Moderna CEO: We expect to know if Covid-19 vaccine works in NovemberПодробнее

Moderna CEO Stephane Bancel talks business, vaccine demand, and medical advancesПодробнее

Moderna CEO on side effects of combination vaccineПодробнее

Moderna CEO on Covid-19 vaccine timeline, how it might be distributed and moreПодробнее

Moderna CEO on raising Covid vaccine manufacturing goalsПодробнее

Moderna CEO on partnering with Lonza, logistical challenges of scaling a vaccineПодробнее

COVID vaccine manufacturer Moderna’s CEO discusses the company’s Q3 earningsПодробнее

Moderna CEO Says Covid-19 Vaccine a ‘Game Changer’Подробнее

Moderna CEO Stephane Bancel on the outlook for the extending timeline of mRNA technology efficacyПодробнее

How Moderna And Pfizer-BioNTech Developed Vaccines In Record TimeПодробнее

Moderna CEO Stéphane Bancel - Bringing Exponentials to PharmaПодробнее

Moderna CEO on its 94.5% effective Covid-19 vaccine: We hope to get it to market soonПодробнее

Moderna CEO: 'Vaccines are one of the best investments we can make'Подробнее

Moderna CEO appears before Senate Hearing on COVID-19 vaccine pricingПодробнее

Coronavirus vaccine: Moderna CEO discusses COVID-19 vaccine development and timelineПодробнее

Moderna CEO is hopeful that a vaccine may be ready for FDA approval by the end of the yearПодробнее